Eden, the leading health platform connecting individuals with licensed providers and pharmacies focused on metabolic health, announced expanded access to a pharmacy-grade compounded glutathione injection protocol. The therapy is now available for eligible individuals in most states through Eden's network of licensed providers and pharmacies.
This provider-guided injection protocol may be considered for individuals seeking support related to oxidative stress, lifestyle recovery, or general wellness goals, all under the supervision of a licensed clinician. The compounded formulation is dispensed by state-licensed compounding pharmacies and delivered directly to eligible patients' homes.
"Oxidative balance is an emerging area of interest for people pursuing wellness and longevity strategies," said Adam McBride, CEO of Eden. "At Eden, we connect members with independent licensed providers to explore evidence-informed options that may align with their personal goals, without relying on in-clinic visits or unverified supplements."
"While more research is needed, preliminary studies suggest glutathione may support antioxidant activity in the body," said Dr. Rebecca Emch, VP of Pharmacy and Medical Operations at Eden. "By offering access to this therapy through licensed medical guidance, we aim to make care more informed and convenient."
"Our goal at Eden is to simplify the path to personalized care," said Josh Khan, President and Co-Founder of Eden. "By helping people access independent licensed providers and trusted pharmacies from the comfort of home, we're lowering barriers and empowering smarter choices about health."
For more information please visit, www.eden.com
